Related references
Note: Only part of the references are listed.Efficient Presentation of Soluble Antigen by Cultured Human Dendritic Cells Is Maintained by Granulocyte/Macrophage Colony-stimulating Factor Plus Interleukin 4 and Downregulated by Tumor Necrosis Factor α
Federica Sallusto et al.
JOURNAL OF IMMUNOLOGY (2018)
IL4Rα+ Myeloid-Derived Suppressor Cell Expansion in Cancer Patients
Susanna Mandruzzato et al.
JOURNAL OF IMMUNOLOGY (2009)
Myeloid-derived suppressor cells as regulators of the immune system
Dmitry I. Gabrilovich et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Endogenous Interleukin-4 Promotes Tumor Development by increasing Tumor Cell Resistance to Apoptosis
Zhiguang Li et al.
CANCER RESEARCH (2008)
Myeloid-derived suppressor cells promote cross-tolerance in B-cell lymphoma by expanding regulatory T cells
Paolo Serafini et al.
CANCER RESEARCH (2008)
Regulatory T cells and immune tolerance
Shimon Sakaguchi et al.
CELL (2008)
Subsets of myeloid-derived suppressor cells in tumor-bearing mice
Je-In Youn et al.
JOURNAL OF IMMUNOLOGY (2008)
Reversion of immune tolerance in advanced malignancy: modulation of myeloid-derived suppressor cell development by blockade of stem-cell factor function
Ping-Ying Pan et al.
BLOOD (2008)
Tumor refractoriness to anti-VEGF treatment is mediated by CD11b+Gr1+ myeloid cells
Farbod Shojaei et al.
NATURE BIOTECHNOLOGY (2007)
Cross-talk between T cells and innate immune cells is crucial for IFN-γ-dependent tumor rejection
Zhiguang Li et al.
JOURNAL OF IMMUNOLOGY (2007)
Tumor necrosis factor receptor 2-mediated tumor suppression is nitric oxide dependent and involves angiostasis
Xueqiang Zhao et al.
CANCER RESEARCH (2007)
Arginase, prostaglandins, and myeloid-derived suppressor cells in renal cell carcinoma
Augusto C. Ochoa et al.
CLINICAL CANCER RESEARCH (2007)
The terminology issue for myeloid-derived suppressor cells
Dmitry I. Gabrilovich et al.
CANCER RESEARCH (2007)
Regulatory T cells and cancer
Helen Y. Wang et al.
CURRENT OPINION IN IMMUNOLOGY (2007)
Gr-1+CD115+ immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host
B Huang et al.
CANCER RESEARCH (2006)
Tumor-associated CD8+ T cell tolerance induced by bone marrow-derived immature myeloid cells
S Kusmartsev et al.
JOURNAL OF IMMUNOLOGY (2005)
Phase I trial of intravenous IL-4 Pseudomonas exotoxin protein (NBI-3001) in patients with advanced solid tumors that express the IL-4 receptor
L Garland et al.
JOURNAL OF IMMUNOTHERAPY (2005)
IL-4-transfected tumor cell vaccines activate tumor-infiltrating dendritic cells and promote type-1 immunity
J Eguchi et al.
JOURNAL OF IMMUNOLOGY (2005)
Mechanisms and functional significance of tumour-induced dendritic-cell defects
D Gabrilovich
NATURE REVIEWS IMMUNOLOGY (2004)
Expansion of myeloid immune suppressor Gr+CD11b+cells in tumor-bearing host directly promotes tumor angiogenesis
L Yang et al.
CANCER CELL (2004)
Tumor rejection by modulation of tumor stromal fibroblasts
T Schüler et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
The role of IFN-γ in tumor transplantation immunity and inhibition of chemical carcinogenesis
T Blankenstein et al.
CURRENT OPINION IN IMMUNOLOGY (2003)
Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth
D Lyden et al.
NATURE MEDICINE (2001)
Interleukin (IL)-4 is a major regulatory cytokine governing bioactive IL-12 production by mouse and human dendritic cells
H Hochrein et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
IL-4 is a mediator of IL-12p70 induction by human Th2 cells: Reversal of polarized Th2 phenotype by dendritic cells
P Kalinski et al.
JOURNAL OF IMMUNOLOGY (2000)
Gr-1+ myeloid cells derived from tumor-bearing mice inhibit primary T cell activation induced through CD3/CD28 costimulation
SA Kusmartsev et al.
JOURNAL OF IMMUNOLOGY (2000)
CD4+ T cell-mediated tumor rejection involves inhibition of angiogenesis that is dependent on IFNγ receptor expression by nonhematopoietic cells
ZH Qin et al.
IMMUNITY (2000)
Share Paper
